| Page 908 | Kisaco Research
 

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

 

Jamie White

Government Affairs Manager and Women's Health Director
G2G Consulting

Jamie White

Government Affairs Manager and Women's Health Director
G2G Consulting

Jamie White

Government Affairs Manager and Women's Health Director
G2G Consulting
 

Hasti Nazem

Head of Product & Education
Kindra

Hasti is part of the founding team of Kindra, leading product development and education. Kindra is developing innovative estrogen-free solutions targeting the top pain points of the 34+ symptoms of menopause. With nearly 10 years of experience at the intersection of life sciences, health and wellness, and consumer brand building, Hasti integrates targeted product formulation development with cutting edge technical advancements. Her deep scientific communications experience helps to empower consumers to better understand their health, and bridge gaps often overlooked in women's health.

Hasti Nazem

Head of Product & Education
Kindra

Hasti Nazem

Head of Product & Education
Kindra

Hasti is part of the founding team of Kindra, leading product development and education. Kindra is developing innovative estrogen-free solutions targeting the top pain points of the 34+ symptoms of menopause. With nearly 10 years of experience at the intersection of life sciences, health and wellness, and consumer brand building, Hasti integrates targeted product formulation development with cutting edge technical advancements. Her deep scientific communications experience helps to empower consumers to better understand their health, and bridge gaps often overlooked in women's health. Hasti's work has been featured in has been featured in The New York Times, Forbes.com, (O) Oprah Magazine, Harper's Bazaar, Women's Health Magazine, and in healthcare public affairs and pharmaceutical trade association publications.

 

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals
 

Dina Radenkovic

CEO & CO-Founder
Gameto

Dina Radenkovic

CEO & CO-Founder
Gameto

Dina Radenkovic

CEO & CO-Founder
Gameto
 

Denise Pines

Founder
The FemAging Project

Denise Pines

Founder
The FemAging Project

Denise Pines

Founder
The FemAging Project
 

Daisy Robinton

CEO & CO-Founder
Oviva Therapeutics

Dr. Daisy Robinton is passionate about elevating women’s health and challenging the status quo of female aging. She launched Oviva Therapeutics with the vision to tackle aging in women while addressing the historic gender disparity in biomedical research and healthcare. Dr. Robinton completed her PhD in Human Biology and Translational Medicine at Harvard University and landed on the Forbes 30 Under 30 list for her scientific discoveries. Her writing has been published in periodicals such as Nature, Vanity Fair and NEO.LIFE.

Daisy Robinton

CEO & CO-Founder
Oviva Therapeutics

Daisy Robinton

CEO & CO-Founder
Oviva Therapeutics

Dr. Daisy Robinton is passionate about elevating women’s health and challenging the status quo of female aging. She launched Oviva Therapeutics with the vision to tackle aging in women while addressing the historic gender disparity in biomedical research and healthcare. Dr. Robinton completed her PhD in Human Biology and Translational Medicine at Harvard University and landed on the Forbes 30 Under 30 list for her scientific discoveries. Her writing has been published in periodicals such as Nature, Vanity Fair and NEO.LIFE. Her work as a molecular biologist, writer, public speaker, and lifestyle & fitness model, contribute to the unique lens with which she examines the intersection of science and culture.

 

Carolee Lee

Founder
Women's Health Access Matters

Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives.

Carolee Lee

Founder
Women's Health Access Matters

Carolee Lee

Founder
Women's Health Access Matters

Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

 

Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

 

 

Andrew Khair

PhD, MBA, Director of Strategy, Business Development and New Product Planning
Ferring Pharmaceuticals

Andrew Khair

PhD, MBA, Director of Strategy, Business Development and New Product Planning
Ferring Pharmaceuticals

Andrew Khair

PhD, MBA, Director of Strategy, Business Development and New Product Planning
Ferring Pharmaceuticals
 

Alice Zheng

Principal
RH Capital

Alice Zheng

Principal
RH Capital

Alice Zheng

Principal
RH Capital